Abstract:Cardiovascular diseases (CVDs) are common causes of death, which take about 18.6 million lives worldwide every year. Currently, exploring strategies that delay ventricular remodeling, reduce cardiomyocyte death, and promote cardiomyocyte regeneration has been the hotspot and difficulty of the ischemic heart disease (IHD) research field. Previous studies indicate that piwi-interacting RNA (piRNA) plays a vital role in the occurrence and development of cardiac remodeling and may offer novel therapeutic strategies for cardiac repair. The best-known biological function of piRNA is to silence transposons in cells. In the cardiovascular system, piRNA is known to participate in cardiac progenitor cell proliferation, AKT pathway regulation, and cardiac remodeling and decompensation. In this review, we systematically discuss the research progress on piRNA in CVDs, especially the mechanism of cardiac remodeling and the potential functions in cardiac protection, which provides new insights for the progress and treatment of cardiovascular diseases. Piwi-interacting RNA (piRNA) is one of the noncoding RNAs, with the best -known biological function to silence transposons in cells. Now piRNA is found to participate in cardiac progenitor cell proliferation, AKT pathway regulation, cardiac remodeling and decompensation, which implies the potential of piRNA in the diagnosis and treatment of cardiovascular diseases. Over expression of piRNA could promote cardiac apoptosis and cardiac hypertrophy, thus targeted therapy which inhibits expression of associated piRNA may reduce cardiac remodeling and reduce inflammation caused by necrotic cardiomyocytes. PiRNA is also speculated to participate in the proliferation of cardiac progenitor cells, implying the potential to induce cardiac regeneration th erapy, which provides new insights for treatment of cardiovascular diseases. At present, the treatment strategy of cardiac remodeling emphasizes the control of risk factors, prevention of disease progression and individualized treatment. With further studies in mechanism of piRNA, potential therapies above may come true and more therapies in cardiovascular diseases may be found.

PIWI-interacting RNAs and PIWI proteins in diabetes and cardiovascular disease: Molecular pathogenesis and role as biomarkers

Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases

piRNAs as emerging biomarkers and physiological regulatory molecules in cardiovascular disease

Current Understanding of Pirna in Cardiovascular Diseases

PiRNA in Cardiovascular Disease: Focus on Cardiac Remodeling and Cardiac Protection

Emerging functions of piwi‐interacting RNAs in diseases

Novel Roles of PIWI Proteins and PIWI-interacting RNAs in Human Health and Diseases

PIWI-interacting RNAs: Critical roles and therapeutic targets in cancer

PIWI-Interacting RNAs: A Pivotal Regulator in Neurological Development and Disease

PIWI Proteins and PIWI-Interacting RNA: Emerging Roles in Cancer.

PIWI-interacting RNA in cancer: Molecular mechanisms and possible clinical implications

PIWI-interacting RNAs in Human Cancer.

The emerging role of the piRNA/piwi complex in cancer

PIWI-interacting RNAs: Mitochondria-based biogenesis and functions in cancer

Emerging Roles and Potential Application of PIWI-interacting RNA in Urological Tumors

CircRNAs in diabetic cardiomyopathy

Non-coding RNAs in Diabetes Mellitus and Diabetic Cardiovascular Disease

Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease.

Somatic piRNA and PIWI-mediated post-transcriptional gene regulation in stem cells and disease

miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

Circular RNAs in Diabetes and Its Complications: Current Knowledge and Future Prospects